droxidopa has been researched along with Degenerative Diseases, Central Nervous System in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Otero-Losada, M; Pérez-Lloret, S; Quarracino, C; Rascol, O | 1 |
| Freeman, R; Goldstein, DS; Holmes, C; Kaufmann, H; Nardin, R; Saadia, D; Voustianiouk, A; Yahr, MD | 1 |
1 review(s) available for droxidopa and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases.
Topics: Amyloid Neuropathies, Familial; Blood Pressure; Droxidopa; Humans; Hypotension, Orthostatic; Japan; Neurodegenerative Diseases; Parkinson Disease; Renal Dialysis; Surveys and Questionnaires | 2019 |
1 trial(s) available for droxidopa and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Norepinephrine precursor therapy in neurogenic orthostatic hypotension.
Topics: Administration, Oral; Aged; Antiparkinson Agents; Aromatic-L-Amino-Acid Decarboxylases; Blood Pressure; Carbidopa; Cross-Over Studies; Double-Blind Method; Droxidopa; Female; Hemodynamics; Humans; Hypotension, Orthostatic; Male; Middle Aged; Neurodegenerative Diseases; Norepinephrine; Posture; Single-Blind Method; Treatment Outcome | 2003 |